THE HSE has splashed out over €200million on weight-loss jabs in less than three years. And it’s emerged that 80,000 patients ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major ...

Just under €212m was spent on Ozempic and Saxenda under the medical card, Drugs Payment Scheme and Long-Term Illness schemes in two years and eight months ...

Fat jabs could be triggering a surge in Brits needing their gallbladders removed, a shock investigation revealed today. ...